Responses
Other responses
Jump to comment:
- Published on: 24 July 2017
- Published on: 7 July 2017
- Published on: 24 July 2017Re:Antenatal management of Cystic Pulmonary adenomatoid malformationShow More
Dear Dr Kumar,
Thank you for your letter.
In relation to the points raised:
1. Much of the evidence for successful use of steroids in CPAMs relates to microcystic lesions. In this case, the lesion was a large macrocystic CPAM. The case was discussed at an antenatal MDT, and the decision not to treat with steroids was reached.
2. We thank you for your comment on measuring baseline and...
Conflict of Interest:
None declared. - Published on: 7 July 2017Antenatal management of Cystic Pulmonary adenomatoid malformationShow More
We read case report by Cullen et al and found it very interesting. It was a successfully managed case however, I have certain queries regarding management in the index case.
1. In a prenatally detected CPAM (previously known as CCAM) with hydrops detected prior to 32 weeks, there is a well-defined role of maternal steroids.(1) Even multiple courses of betamethasone can be tried. Whether it was thought off in inde...
Conflict of Interest:
None declared.